EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity

Cancer Research

Volumn 67, Issue 10, 2007, Pages 4665-4670

  Vikis, Haris ^a   Sato, Mitsuo ^b   James, Michael ^a   Wang, Daolong ^a   Wang, Yian ^a   Wang, Min ^a   Jia, Dongmei ^a   Liu, Yan ^a   Bailey Wilson, Joan E ^c   Amos, Christopher I ^d   Pinney, Susan M ^e   Petersen, Gloria M ^f   De Andrade, Mariza ^f   Yang, Ping ^f   Wiest, Jonathan S ^g   Fain, Pamela R ^h   Schwartz, Ann G ⁱ   Gazdar, Adi ^b   Gaba, Colette ^j   Rothschild, Henry ^k   Mandal, Diptasri ^k   Kupert, Elena ^e   Seminara, Daniela ^g   Viswanathan, Avinash ^a   Govindan, Ramaswamy ^a   Minna, John ^b   Anderson, Marshall W ^e   You, Ming ^a,l   more..

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF CINCINNATI   (United States)

^f Mayo Clinic   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ KARMANOS CANCER INSTITUTE   (United States)

^j MEDICAL COLLEGE OF OHIO   (United States)

^k LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^l USA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GEFITINIB; PHOSPHOTRANSFERASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ALLELES; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, NEOPLASM; GENES, ERBB-1; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LUNG NEOPLASMS; PEDIGREE; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 34250329445     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0217     Document Type: Article

References (23)

1. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
2. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;304:1497-500.
3. Pao W, Miller V, Zakowski M, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 2004; 101:13306-11.
4. Kobayashi S, Boggon TJ, Dayaram T, et al. EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med 2005;352:786-92.
5. Pao W, Miller VA, Politi KA, et al. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med 2005;2:e73.
6. Kwak EL, Sordella R, Bell DW, et al. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc Natl Acad Sci U S A 2005; 102:7665-70.
7. Deininger M, Buchdunger E, Druker BJ. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005;105:2640-53.
8. Bell DW, Gore I, Okimoto RA, et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR. Nat Genet 2005;37:1315-6.
9. Blencke S, Ullrich A, Daub H. Mutation of threonine 766 in the epidermal growth factor receptor reveals a hotspot for resistance formation against selective tyrosine kinase inhibitors. J Biol Chem 2003;278:15435-40.
10. Blencke S, Zech B, Engkvist O, et al. Characterization of a conserved structural determinant controlling protein kinase sensitivity to selective inhibitors. Chem Biol 2004;11:691-701.
11. Sato M, Vaughan MB, Girard L, et al. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 2006;66:2116-28.
12. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004;75:460-74.
13. Rojas M, Yao S, Lin YZ. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 1996;271:27456-61.
14. Kobayashi S, Shimamura T, Monti S, et al. Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling. Cancer Res 2006;66:11389-98.
15. Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64: 8919-23.
16. Yamamoto M, Kurosu T, Kakihana K, Mizuchi D, Miura O. The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase. Biochem Biophys Res Commun 2004;319:1272-5.
17. Garcia de Palazzo IE, Adams GP, Sundareshan P, et al. Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas. Cancer Res 1993;53: 3217-20.
18. Moscatello DK, Holgado-Madruga M, Godwin AK. et al. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res 1995;55:5536-9.
19. Inukai M, Toyooka S, Ito S, et al. Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer. Cancer Res 2006;66:7854-8.
20. Sellers TA, Bailey-Wilson JE, Elston RC, et al. Evidence for mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 1990;82:1272-9.
21. Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol 1999;17:253-73.
22. Chen PL, Sellers TA, Bailey-Wilson JE, Rothschild H, Elston RC. Segregation analysis of smoking-associated malignancies: evidence for mendelian inheritance. Am J Hum Genet 1991:49.
23. Bunn PAJ, Soriano A. New therapeutic strategies for lung cancer: biology and molecular biology come of age. Chest 2000;117:163-8S.